NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE was delisted on the 10th of May, 2024.
13 hedge funds and large institutions have $1.12M invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
65% more capital invested
Capital invested by funds: $677K → $1.12M (+$439K)
13% less funds holding
Funds holding: 15 → 13 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$129K |
| 2 |
FIA
FNY Investment Advisers
New York
|
+$86.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.25K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.83K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$1.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
-$104K |
| 2 |
MIG
Mariner Investment Group
Harrison,
New York
|
-$21.9K |
| 3 |
WAM
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $729K | +$129K | +2,271 | +27% |
|
|
FIA
2
FNY Investment Advisers
New York
| $104K | +$86.4K | +1,526 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $91K | – | – | – |
|
4
BlackRock
New York
| $71K | – | – | – |
|
|
MIG
5
Mariner Investment Group
Harrison,
New York
| $57K | -$21.9K | -387 | -32% |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $54K | +$7.25K | +128 | +19% |
|
|
7
UBS Group
Zurich,
Switzerland
| $4K | +$2.83K | +50 | +500% |
|
|
SSB
8
Sandy Spring Bank
Olney,
Maryland
| $2K | +$396 | +7 | +39% |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | +$1.3K | +23 | New |
|
|
CLOS
10
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $1K | – | – | – |
|
11
First Manhattan
New York
| $1K | – | – | – |
|
|
12
Creative Planning
Overland Park,
Kansas
| – | -$104K | -2,308 | Closed |
|
|
WAM
13
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| – | -$1K | -25 | Closed |
|
14
Morgan Stanley
New York
| – | +$57 | +1 | +10% |
|
NBSE Hedge Fund Activity: Q2 2019 in Review
13 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q2 2019, worth a combined $1.12M — up 65% from $677K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NBSE and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $129K. The largest seller was Creative Planning, exiting entirely with an estimated $104K sold.
- 13 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q2 2019, down from 15 in Q1 2019.
- Funds reported $1.12M of NeuBase Therapeutics, Inc. Common Stock stock for Q2 2019, up 65% quarter-over-quarter.
- 2 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q2 2019 and 4 closed out, a net change of -2 holders.
- The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q2 2019 was Renaissance Technologies, an estimated $129K added.
- The largest NeuBase Therapeutics, Inc. Common Stock seller in Q2 2019 was Creative Planning, an estimated $104K sold.
Based on aggregated 13F filings for Q2 2019.